US Mice Model Market Projected to Grow at 6.16% CAGR from 2025 to 2034, Supported by Advances in Genetic Engineering and Animal Model Technologies | DataM Intelligence

Leander, Texas and TOKYO, Japan - The United States Mice Model Market is valued at approximately USD 6.55 billion in 2024 and is projected to reach about USD 11.91 billion by 2034, growing at a CAGR of around 6.16% during the forecast period from 2025 to 2034.

This growth is driven by advancements in gene editing tools, increased demand for humanized mice models, physiological similarities between humans and mice, and rising consumption of personalized medicine.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/mice-model-market?ram

United States: Key Industry Developments

✅ November 2025: The global mice model market reached a size of around USD 1.73 billion in 2025, with a robust growth driven by advancements in genetic engineering such as CRISPR that enable precise production of disease-specific mouse models for pharmaceutical and research purposes.

✅ October 2025: North America's mice model market, led by the U.S., showed strong growth supported by state-of-the-art biomedical research facilities and significant investment from pharmaceutical and biotechnology companies, propelling demand for personalized medicine and complex genetic models.

✅ July 2025: Genetically engineered mice models, especially those using CRISPR multiplexing for complex allele combinations, were experiencing a CAGR of 10.00%, highlighting a significant market expansion in oncology and neurodegenerative disease research.

Asia Pacific / Japan: Key Industry Developments

✅ November 2025: The mice model market in Asia Pacific, including Japan, is growing due to increasing adoption of personalized medicine and gene editing technologies, with rising demand in immunology and cancer research utilizing hybrid and humanized mouse models.

✅ September 2025: Japan's mice model services market is expanding with enhanced applications in biomedical research, driven by robust biotechnology and pharmaceutical sectors adopting advanced models for preclinical studies.

✅ July 2025: The Asia Pacific region, including Japan, saw increased emphasis on specialized mice models for complex disease research, supported by governmental and private sector initiatives focusing on innovative biotechnology solutions and personalized healthcare approaches.

Key Mergers and Acquisitions (2025):

✅ Charles River Laboratories - expanded its mice model portfolio through strategic acquisitions, enhancing its market position and capabilities in providing diverse and advanced mice models for research and development.

✅ Taconic Biosciences - engaged in strategic collaborations and acquisitions to develop innovative mice models, strengthening its technological edge and product offerings in the preclinical research sector.

✅ Inotiv - significantly expanded its capabilities and market reach through acquisitions of companies such as Histion, Orient BioResource Center, Integrated Laboratory Systems, and Robinson Services, broadening its strains portfolio and services including surgical models and toxicology.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=mice-model-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:

- The rising adoption of mice models in preclinical studies due to their genetic and physiological versatility is a primary driver.

-Advancements in genetic engineering techniques like CRISPR are enabling the creation of more disease-specific and humanized models, thus accelerating research and drug development.

-The increasing demand for personalized medicine, especially in oncology, prompts the need for tailored mouse models that accurately mimic human disease conditions.

-The expanding use of mice models in mouse clinical trials (MCTs) supports faster and more reliable testing of new therapies.

-Growing biomedical research investments, particularly in regions like Asia-Pacific, are fueling demand for genetically modified and disease-specific mice models.

-Technological innovations such as AI-powered data analysis and alternative animal models further enhance the efficiency and scope of research utilizing mice models, ensuring sustained growth of the market

Market Segmentation Analysis:

-By Type

Outbred Mice: Expected to be the fastest-growing segment due to genetic diversity benefits for complex disease modeling.

Genetically Engineered Mice: Rapidly growing segment driven by CRISPR and other gene-editing technologies, holds especially strong growth prospects in oncology and neurodegenerative disease research.

Hybrid/Congenic Mice: Used for specific research requiring mixed genetic backgrounds.

Others: Includes immunodeficient, humanized, and transgenic mice.

-By Service

Breeding: Core service with steady demand.

Cryopreservation: Growing importance for genetic preservation.

Model In-Licensing: Increasing as pharma/biotech prefer outsourcing model access.

Genetic Testing: Rising due to quality control and research precision.

Other Services: Include colony management, phenotype characterization.

-By Technology

CRISPR/CAS9: Largest and fastest-growing tech segment with more than 34% market share in 2024, enabling precise and multiplex genetic modifications.

Embryonic Stem Cell Injection: Established technology for transgenics.

Nuclear Transfer: Used for cloning and complex genetic models.

Other Technologies: Include microinjection and RNA interference methods.

-By Application

Oncology: Dominant application area driving market growth due to high demand for cancer research models.

Others: Includes neurological, metabolic, infectious disease, and immunology research.

-By End User

Pharmaceutical & Biotechnology Companies: Largest users for drug discovery and preclinical testing.

Contract Research Organizations (CROs): Growing segment supporting outsourced R&D.

Academic & Research Institutions: Significant users for fundamental and disease research.

Others: Includes government labs and non-profit research organizations.

Regional Insights:

North America: This region dominates the mice model market with the largest share, holding approximately 35-40% of the global market in 2025. The market size in North America is significant due to advanced biomedical research infrastructure, high incidence of chronic diseases such as cancer, diabetes, and infectious diseases, and strong financial and regulatory support for personalized medicine and preclinical research. The United States and Canada are major contributors to this dominance, driven by developments in biotechnology, monoclonal antibodies, and tailored therapies.

Asia-Pacific: Asia-Pacific is the fastest-growing region in the mice model market, expected to record the highest CAGR through the forecast period. Growth is propelled by rapid expansion in pharmaceutical and biotech industries in China, India, Japan, and South Korea. Key drivers include rising investments in drug discovery, personalized medicine, translational research, and regulatory mandates for animal testing. Additionally, the establishment of advanced vivariums, increased demand for genetically engineered and humanized mice, and favorable government support nurture the market expansion in this region.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/mice-model-market?ram

Key Players:

Charles River Laboratories | genOway | Aragen Bioscience | Taconic | Oragenics Inc | Innovative | Jackson Laboratory | FENGSHI Group | Cyagen

Key Highlights (Top 5 Key Players) for Mice Model Market:

-Charles River Laboratories reported a significant market presence with extensive offerings of over 150 specialized mouse strains and integrated services supporting pharmaceutical, biotech, CROs, academic, and government clients globally. The company's strategic expansion and innovation initiatives, including a USD 200 million project for alternative testing methods, position it strongly in the market.

-The Jackson Laboratory is a prominent nonprofit institution known for its advanced genetic engineering mouse models used in preclinical drug research. It invests heavily in R&D and holds patents for novel methodologies, reinforcing its leadership in translational science.

-Taconic Biosciences specializes in genetically engineered, immune-oncology, and diet-induced mouse models, offering high-quality breeding and research services in North America.

-genOway (France) is recognized for its specialized genetically engineered mice models, contributing to personalized medicine and preclinical studies.

-Cyagen Biosciences provides diverse mouse models, including humanized and immunodeficient strains, supporting a wide range of biomedical research applications.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.